Abstract 15108: Apixaban versus Warfarin in Patients with Atrial Fibrillation and End-Stage Kidney Disease on Hemodialysis: A Propensity-Matched Real-World Analysis
Introduction/Background: Patients with atrial fibrillation (AF) and end-stage kidney disease (ESKD) undergoing maintenance hemodialysis are at high risk for both thromboembolic and bleeding events. Comparative effectiveness and safety data for apixaban versus warfarin in this population remain limited. Research...